Vor Biopharma Inc.
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hemato…
Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents
Employees Analysis
Value per Employee (VpE) · Surveys · Talents
Employee Surveys
Employees Asked: -No survey available at the moment.